Dr Eliangiringa Kaale is a Professor of Medicines Quality Assurance and Regulatory Affairs at the Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania. With more than 23 years of experience, he has worked extensively on strengthening medicines regulatory systems across Africa and beyond, including in Tanzania, Rwanda, Botswana, Zambia, Eritrea, Ethiopia, and Afghanistan.
His research focuses on medicine quality assurance and regulatory strengthening, with notable contributions to child-friendly HIV formulations, generic medicines, and digital tools to support quality assessment in remote areas. He has also played a leading role in building laboratory capacity, developing quality management systems, and promoting regional and continental collaboration in regulatory science.
He serves on global expert panels with the WHO and the USP, and chairs Tanzania’s committees on medicines registration and pharmaceutical standards. In recognition of his work, he received the prestigious Alexander von Humboldt Fellowship in 2012 and has published more than 100 scientific papers.
Dr Kaale leads the TMDA–MUHAS Regional Centre of Regulatory Excellence, coordinates a continental external quality assurance proramme for medicine testing laboratories, and is currently the coordinator of a large project on Strengthening Healthcare Supply Chain Management and Education in Tanzania, aimed at improving access to quality health commodities.
Emily is an internal medicine physician and commenced her DPhil in October 2024 supported by a Medical Research Council Clinical Research Training Fellowship. Under the supervision of Prof. Richard Price, A/Prof. Robert Commons, Dr. James Watson, and A/Prof. Sarah Auburn, her DPhil will generate evidence to define the efficacy and safety of different treatment strategies for Plasmodium vivax malaria.
Emily completed her medical training at the Universities of Cambridge and Oxford and spent a year as a Herchel Smith Scholar at Harvard University where she studied Global Health. She has worked as a clinician in Oxford, Reading, and London, and spent a year as an International Fellow in Tropical Medicine at the Menzies School of Health Research in Darwin, Australia, in 2020-21. She co-ordinated a collaborative project through the WorldWide Antimalarial Resistance Network to define parasitaemia thresholds for diagnosing vivax malaria and conducted systematic reviews and meta-analyses on severe haemolysis during primaquine treatment for P. vivax.
Qualifications
- MRCP(UK)
- BMBCh (Oxon) – Distinction, Meakins-McClaran Medal for the highest performance
- MA (Cantab) in Pre-Clinical Medicine (Part II Pharmacology) – First Class Honours
Nathalie is a medical doctor. She graduated from the University of Ouagadougou in Burkina Faso and earned a Master’s in Public Health from the University of Bordeaux. She has over a decade of experience in clinical research and healthcare delivery in Burkina Faso with the Ministry of Health, and in The Gambia with the Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine (MRCG at LSHTM) as a Research Clinician/study coordinator on various studies (malaria, maternal and neonatal mortality and sepsis, and child neuro development).
Nathalie is registered for a PhD at the University of Barcelona data on intrapartum related asphyxia in sub–Saharan African.
She is currently a WHO/TDR fellow on clinical research leadership at IDDO for 12 months to develop competencies on evidence synthesis, meta-analysis, statistical methodology, data governance infrastructure, and data privacy. Her research will investigate the utilisation and access to the antenatal cares in Kenya and Burkina using the data from MiMBa registry.
Juan is a physician with a master's degree in epidemiology and certified as a field epidemiologist by the National Institute of Health of Colombia, Tephinet, and the CDC. He has experience in clinical care, public health, and research. Juan currently works at CIDEIM in Colombia as a medical researcher, specifically focusing on malaria recurrence and malaria associations with climate change. Other responsibilities include biostatistical analysis and data management.
His research career focuses on analytical methodologies that integrate data from public health surveillance and clinical care to strengthen evidence-based interventions. Juan is currently a TDR/WHO Clinical Research and Leadership Fellow at IDDO. His participation in IDDO is based on learning about neglected tropical diseases such as leishmaniasis and malaria using methodologies for data analysis and management, combining information from national surveillance systems and clinical research for early detection and response to infectious disease threats, including results for decision-making in public health policies.
Boris-Enock Zinsou is a PhD candidate in Public Health at Université Paris Cité (IRD - MERIT) under the joint supervision of Dr. Jérôme Clain (IRD – MERIT), Professor Philippe Guérin, and Dr. Lucinda Harrison. Within the IDDO, his research focuses on the spatial, genetic, and epidemiological dynamics of Plasmodium falciparum resistance to antimalarial drugs in West Africa and the Sahel, particularly in the context of chemoprevention strategies.
He holds a Master’s degree in Public Health from the École Pasteur-Cnam de Santé Publique (France), a Master’s degree in Microbiology from Cheikh Anta Diop University (Senegal), and a Bachelor’s degree in Biomedical Analysis from the University of Abomey-Calavi (Benin).
Before starting his PhD, Boris-Enock Zinsou began his career as a research engineer in virology at the Virology Department of the Institut Pasteur in Dakar (Senegal), where he contributed to the WHO Global Polio Eradication Program, ensuring virological surveillance for six West African countries.
During the COVID-19 pandemic, he joined the Reference Laboratory for Viral Hemorrhagic Fevers in Cotonou (Benin), where he participated in diagnostic activities.
He then served as a biological engineer and laboratory manager at the Clinical Research Institute of Benin (IRCB). He played a key role in a multicenter clinical trial evaluating the efficacy of a triple therapy against uncomplicated malaria in African children.
Finally, he worked as a consultant biologist for the Ministry of Health of Benin, the U.S. Centers for Disease Control and Prevention (CDC), and SIGHTSAVERS, where he contributed to the evaluation of new diagnostic tools for onchocerciasis.
His research interests include epidemiology, disease modeling, and infectious disease control, with a particular focus on challenges related to climate change and fragile health systems, especially in resource-limited settings.
Dr Thel Hla is a visiting researcher with the IDDO antimicrobial resistance research team. She is an infectious diseases physician by training (MBBS, DTM&H, FRACP) and holds a senior research officer position with The Kids Research Institute (Australia). She has previously worked as a researcher with Myanmar Oxford Clinical Research Unit (MOCRU) in 2019 -2020.
She is currently completing a doctoral thesis focussing on re-purposing penicillins to improve secondary prophylaxis against Strep A, centred around a randomised, controlled Strep A human challenge study. Her other research involvements include demonstration of safety and feasibility of subcutaneous infusion of high dose long-acting penicillin in healthy human volunteers, paving the way for improving treatment of syphilis infection and secondary prophylaxis of rheumatic heart disease.
Mary joined IDDO in January 2025 as a Data Scientist to perform large-scale individual patient data meta-analyses, methods development, and statistical modelling to optimise the treatment of infectious disease. Her research will focus on improving the diagnosis and triage of patients with suspected severe malaria.
In February 2025, Mary defended her PhD thesis, titled 'Differentially Private Methods for Releasing Aggregated Multi-Dimensional Messages'. She holds a Bachelor of Science in Mathematics from the University of Warwick.
Key Publications
All Publications
Dhruv is a medical doctor from Zambia with a keen interest in the epidemiology of infectious diseases. At IDDO, Dhruv’s DPhil research focuses on Seasonal Malaria Chemoprevention, supervised by Prof. Philippe Guérin, Dr. James Watson and Dr. Prabin Dahal.
Previously, Dhruv completed the MSc in Global Health Science and Epidemiology in Oxford. He is supported by the Rhodes Scholarship. He aims to pursue specialty clinical training after completing his doctoral research in Oxford.
Lucy joined IDDO in November 2024 to work on geospatial models of anti-malarial drug resistance. Lucy has recently submitted her PhD thesis, titled “Informing public health decisions with geospatial models of vector-borne disease”. During her PhD, she developed geospatial models of Plasmodium knowlesi malaria in Southeast Asia and Japanese encephalitis virus in Australia. She also worked on frameworks for model-informed decision-making for disease surveillance site selection.
Before commencing her PhD, she obtained a Bachelor of Science, majoring in Computational Biology, in 2018 and a Master of Computational Biology in 2020 from the University of Melbourne.
All Publications
Riley joined IDDO in September 2024. As a Data Manager, they work on the management and transformation of diverse data sets that are submitted to IDDO, as well as ensuring the completeness and accuracy of data in the IDDO data repository.
Prior to joining IDDO, they worked as a Data Wrangler for the Oxford-Novartis collaboration where they handled big data from IL-17A inhibitor clinical trials.
Riley holds a MBiol Microbiology/Biotechnology from the University of York and a MSc Data Science from Loughborough University.